Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare ...

Thyrocare Technologies Limited reported a robust 23% year-on-year revenue growth in Q1FY26. The company's core Pathology segment significantly contributed to this surge.

Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new ...

Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...

LIC, Lupin, Divi's, 3M India, Abbott India, Fortis Healthcare, Bharti Hexacom, Union Bank, Zydus Lifesciences, Orient Cement ...

Mid-market private equity firm Jashvik Capital said Wednesday it is investing over Rs 400 crore ($45.7 million) in Marg ...

Ever looked at your blood test report, seen everything marked "normal," and still felt off? You are not alone. Nutritionist ...

Investors will be watching updates from major names such as Kotak Mahindra Bank, Lodha Developers, Balkrishna Industries, ...

Mumbai: After years of relying on external partnerships, Sion hospital is set to expand its efforts to hunt for drug-resistant tuberculosis by adding .

Stocks like Sun Pharma, eClerx Services, Indian Energy Exchange, Anant Raj, REC, Aether Industries, Larsen & Toubro, Torrent Power, Enviro Infra Engineers, GR Infraprojects, and Adani Enterprises will ...